The endogenous ouabain: Molecular basis of its role in hypertension and cardiovascular complications

Frontiers in Bioscience

Volumn 10, Issue SUPPL. 2, 2005, Pages 2472-2477

  Ferrandi, Mara ^a   Manunta, Paolo ^b   Ferrari, Patrizia ^a   Bianchi, Giuseppe ^b  

^a Prassis Sigma Tau Research Institute   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Adducin; Endogenous Ouabain; Genetic; Hypertension; Hypertrophy; Na+, K+, Atpase; Rat; Review

Indexed keywords

17BETA (3 FURYL) 5BETA ANDROSTANE 3BETA,14BETA,17ALPHA TRIOL; ADDUCIN; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIHYPERTENSIVE AGENT; DIGITOXIGENIN; DIGITOXIGENIN DIGITOXOSIDE; OUABAIN; SODIUM;

ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG SELECTIVITY; GENE; HUMAN; HYPERTENSION; HYPERTROPHY; ISOMER; KIDNEY TUBULE ABSORPTION; MODULATION; NONHUMAN; PATHOPHYSIOLOGY; RAT; SAFETY; SIGNAL TRANSDUCTION; SODIUM URINE LEVEL; TRANSCRIPTION INITIATION; VENOUS PRESSURE;

STROPHANTHUS GRATUS;

EID: 21344466110     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1711     Document Type: Article

References (47)

1. Jorgensen P.L.: Mechanism of the Na-K pump. Protein structure and conformation of the pure Na/K-ATPase. Biochim Biophys Acta 694, 27-68 (1982)
2. Pressley T.A.: Phylogenic conservation of isoform-specific regions within alpha subunit of Na/K-ATPase. Am J Physiol 262, C743-C751 (1992)
3. Hamlyn J.M., M.P. Blaustein, S. Bova, D.W. DuCharme, D. Harris, F. Mandel: Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci 88, 6259-6263 (1991)
4. Hamlyn J.M., Z. Lu, P. Manunta, J.H. Ludens, K. Kimura, J. Shah, J. Laredo, J. Hamilton, M. Hamilton, B. Hamilton: Observations on the nature, biosynthesis, secretion and significance of endogenous ouabain. Clin and Exper Hypertension 20 (5&6), 523-533 (1998)
5. Kawamura A., J. Guo, Y. Itagaki, C. Bell, Y. Wang, G. Haupert, S. Magil, R. Gallagher, N. Berova, K. Nakanishi: On the structure of endogenous ouabain. Proc Natl Acad Sci 96, 6654-6659 (1999)
6. Ferrandi M., P. Manunta, S. Balzan, J.M. Hamlyn, G. Bianchi, P. Ferrari: Ouabain-like factor quantification in human tissues and plasma: comparison of two independent assays. Hypertension 30, 886-896 (1997)
7. Goto A., K. Yamada, M. Ishii, M. Yoshioka, T. Ishiguro, C. Eguchi, T. Sugimoto: Purification and characterization of human urine-derived digitalis like factor. Biochem Biophys Res Commun 154, 847-853 (1988)
8. Fedorova O.V., P.A. Doris, A.Y. Bagrov: Endogenous marinobufagenin-like factor in acute plasma volume expansion. Clin Exp Hypertens 20, 581-591 (1998)
9. Fedorova O.V., M.I. Tala, N.I. Agalakova, E.G. Lakatta, A.Y. Bagrov: Coordinated shifts in Na/K-ATPase isoforms and their endogenous ligands during cardiac hypertrophy and failure in NaCl-sensitive hypertension. J Hypertension 22, 389-397 (2004)
10. Balzan S., D. Neglia, S. Ghione, G. D'Urso, M.C. Baldacchino, U. Montali, A. L'Abbate: Increased circulating levels of ouabain-like factor in patients with asymptomatic left ventricle dysfunction. Eur J Heart Failure 3, 165-171 (2001)
11. D'Urso G., S. Frascarelli, S. Balzan, R. Zucchi, U. Montali: Production of ouabain-like factor in normal and ischemie rat heart. J Cardiov Pharmacol 43, 657-662 (2004)
12. Schneider R, R. Antolovic, H. Kost, B. Sich, U. Kierch, M. Tepel, W. Zidek, W. Schoner: Proscillaridin A immunoreactivity: its purification, transport in blood by a specific binding protein and its correlation with blood pressure. Clin Exp Hypertens 20, 593-600 (1998)
13. Lingrel J.B., J. Orlowski, M.M. Shull, E.M. Price: Molecular genetics of Na/K-ATPase. Prog Nucl Acid Res 38, 37-89 (1990)
14. Ferrari P., G. Bianchi: Lessons from experimental genetic hypertension. In: Hypertension, Pathophysiology, Diagnosis and Management. Eds: Laragh JH, Brenner BM. Raven Press, Ltd, New York 74, 1261-1280 (1995)
15. Bianchi G., U. Fox, G.F. Di Francesco, A.M. Giovanetti, D. Pagetti: Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med 47, 435-448 (1974)
16. Ferrari P., D. Cusi, B.R. Barber, C. Barlassina, G. Vezzoli, L. Duzzi, E. Minotti, G. Bianchi: Erythrocyte membrane and renal function in relation to hypertension in rats of the Milan hypertensive strain. Clin Sci 63, 61s-64s (1982)
17. Bianchi G., G. Tripodi, G. Casari, S. Salardi, B.R. Barber, R. Garcia, P. Leoni, L. Torielli, D. Cusi, M. Ferrandi, L.A. Pinna, F.E. Baralle, P. Ferrari: Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci 91, 3999-4004 (1994)
18. Tripodi G., F. Valtorta, L. Torielli, E. Chieregatti, S. Salardi, L. Trusolino, A. Menegon, P. Ferrari, P.C. Marchisio, G. Bianchi: Hypertension - associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest 97, 2815-2822 (1996)
19. Ferrandi M., G. Tripodi, S. Salardi, M. Florio, R. Modica, P. Barassi, P. Parenti, A. Shainskaia, S. Karlish, G. Bianchi, P. Ferrari: Renal Na/K-ATPase in genetic hypertension. Hypertension 28, 101-1025 (1996)
20. Manunta P., A.C. Rogowski, B.P. Hamilton, J.M. Hamlyn: Ouabain-induced hypertension in the rat: relationship among plasma and tissue ouabain and blood pressure. J Hypertension 12, 549-560 (1994)
21. Ferrari P., L. Torielli, M. Ferrandi, G. Padoani, L. Duzzi, M. Florio, F. Conti, P. Melloni, L. Vesci, N. Corsico, G. Bianchi: PST 2238: a new antihypertensive compound that antagonizes the long-term presser effect of ouabain. J Pharmacol Exp Ther 285, 83-94 (1998)
22. Manunta P., E. Messaggio, I. Ballabeni, M.T. Sciarrone, C. Lanzani, M. Ferrandi, J.M. Hamlyn, D. Cusi, F. Galletti, G. Bianchi: Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension. Hypertension 38, 198-203 (2001)
23. Cusi D., C. Barlassina, T. Azzani, G. Casari, L. Citterio, M. Devoto, N. Glorioso, C. Lanzani, P. Manunta, M. Righetti, R. Rivera, P. Stella, C. Troffa, L. Zagato, G. Bianchi: Polymorphism of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 349, 1353-1357 (1997)
24. Manunta P., M. Burnier, M. D'Amico, L. Buzzi, M. Maillard, C. Barlassina, G. Lanella, D. Cusi, G. Bianchi: Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. Hypertension 33, 694-697 (1999)
25. Ferrari P., M. Ferrandi, G. Tripodi, L. Torielli, G. Padoani, E. Minotti, P. Melloni, G. Bianchi: PST 2238: a new antihypertensive compound that modulates Na/K-ATPase in genetic hypertension. J Pharmacol Exp Ther 288, 1074-1083 (1999)
26. Saunders R., G. Scheiner-Bobis: Ouabain stimulates endothelial release and expression in human endothelial cells without inhibiting the sodium pump. Eur J Biochem 271, 1054-62 (2004)
27. Torielli L., G. Padoani, P. Tarsini, F. Conti, G. Bianchi, P. Ferrari: Adducin may affect the residential time of the Na-K pump on plasma membrane. Europ J Cell Biol 79 suppl. 52, ELSO Proceedings, Abs 164 (2000)
28. Efendiev R., R.T. Krmar, G. Ogimoto, J. Zwiller, G. Tripodi, A.I. Katz, G. Bianchi, C.H. Pedemonte, A.M. Bertorello: Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na/K-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ Res 95, 1100-1108 (2004)
29. Ferrandi M., S. Salardi, G. Tripodi, P. Barassi, R. Goldslager, P. Manunta, P. Ferrari, G. Bianchi, S. Karlish: Evidence for an interaction between adducin and Na/K-ATPase: relation to genetic hypertension. Am J Physiol 277, H1338-1349 (1999)
30. Ferrandi M., I. Molinari, P. Barassi, E. Minotti, G. Bianchi, P. Ferrari: Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238. J Biol Chem 279, 33306-33314 (2004)
31. deWardener H.E., G.A. MacGregor: Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in hypertension. Kidney Int 18, 1-9 (1980)
32. Blaustein M.P.: Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Am J Physiol 232, C165-C173 (1977)
33. Liu J., R. Kesiry, S. Periyasamy, D. Malhotra, Z. Xie, J. Shapiro: Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney International 66, 227-241 (2004)
34. Will P.C., J.W. Longworth, E.T. Broke, J.S. Cook. Analysis of intracellular drug (ouabain) sequestration as a mechanism of detoxification. Mol Pharmacol 13, 161-172 (1977)
35. Wang J., J. Staessen, E. Messaggio, T. Nawrot, R. Fagard, J.M. Hamlyn, G. Bianchi, P. Manunta: Salt, endogenous ouabain and blood pressure interactions in the general population. J Hypertension 21, 1475-81 (2003)
36. Manunta P., P. Stella, R. Rivera, D. Ciurlino, D. Cusi, M. Ferrandi, J.M. Hamlyn, G. Bianchi: Left ventricle mass, stroke volume and ouabain-like factor in essential hypertension. Hypertension 34, 450-456 (1999)
37. Pierdomenico S., A. Bucci, P. Manunta, R. Rivera, M. Ferrandi, J.M. Hamlyn, D. Lapenna, F. Cuccurullo, A. Mezzetti: Endogenous ouabain and hemodynamic and left ventricle geometric patterns in essential hypertension. Am J Hypertension 14, 44-50 (2001)
38. Iacoviello M., R. Vuolni, R. Romita, V. De Luca, P. Manunta, E. Messaggio, F. Massari, G. Bianchi, M.V. Pitzalis, P. Rizzon: Prognostic value of endogenous ouabain plasma levels in idiopathic dilated cardiomyopathy. Italian Heart J vol 2, suppl 6, Abstract C346 (2001)
39. Gottlieb S.S., A. Rogowski, M. Weinberg, C. Krichten, B. Hamilton, J.M. Hamlyn: Elevated levels of endogenous ouabain in patients with congestive heart failure. Circulation 86, 420-425 (1992)
40. Delva P., M.A. Devynch, M. Degan, M.G. Pernollet, M. Carraroli, C. Capra, A. Steele, A. Lechi: Plasma levels of an endogenous Na-K pump inhibitor in relation to haemodynamic data in cardiopathic patients. Clinical Science 81, 23-29 (1991)
41. Xie Z., A. Askari: Na/K-ATPase as a signal transducer. Eur J Biochem 269, 2434-2439 (2002)
42. Haas M., H. Wang, J. Tian, Z. Xie: Src-mediated interreceptor cross-talk between the Na/K-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J Biol Chem 277, 18694-18702 (2002)
43. Quadri L., G. Bianchi, A. Cerri, G. Fedrizzi, P. Ferrari, M. Gobbini, P. Melloni, S. Sputore, M. Torri: 17 beta-(3Furyl)-5 beta androstane 3 beta, 14 beta, 17 alpha triol (PST 2238). A very potent antihypertensive agent with novel mechanism of action. J Med Chem 40, 1561-1564 (1997)
44. Ferrari P., M. Ferrandi, L. Torielli, G. Tripodi, P. Melloni, G. Bianchi: PST 2238: a new antihypertensive compound that modulates Na/K-ATPase and antagonizes the presser effect of OLF. Cardiovascular Drug Reviews 17, 39-57 (1999)
45. Ferrandi M., P. Barassi, E. Minotti, L. Duzzi, I. Molinari, G. Bianchi, P. Ferrari: PST 2238: a new antihypertensive compound that modulates renal Na-K pump function without diuretic activity in Milan Hypertensive rats. J Cardiovascular Pharmacology 40, 881-889 (2002)
46. Doris P.A. Ouabain in plasma from spontaneous hypertensive rats. Am J Physiol 266, H360-H364 (1994)
47. Ferrari P., G. Bianchi: Genetic mapping and tailored antihypertensive therapy. Cardiovasc Drugs and Ther 14, 387-395 (2000)